A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.
As the US death toll from the coronavirus pandemic rises above 146,000 and more than 4 million Americans have tested positive for the virus, the country waits anxiously for approval of a vaccine that will begin to bring the virulent spread under control.
This race for a vaccine will be the topic of the one-hour session featuring experts on viruses and vaccines.
Click here to register for the free event
The panel for this webinar features:
No Rx Required for COVID-19 Vaccination But ACIP Calls for Better Informed Consent Process
September 22nd 2025The ACIP on September 19 narrowly voted against requiring a prescription to get the shot but urged more detailed discussion of vaccine risks during shared decision making conversations.